Author： Fonknechten Nùria
Publisher： Oxford University Press
ISSN： 1460-2083
Source： Human Molecular Genetics, Vol.9, Iss.4, 2000-03, pp. : 637-644
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a group of genetically heterogeneous neurodegenerative disorders characterized by pro‐ gressive spasticity of the lower limbs. Five AD‐HSP loci have been mapped to chromosomes 14q, 2p, 15q, 8q and 12q. The SPG4 locus at 2p21–p22 has been shown to account for ∼40% of all AD‐HSP families. SPG4 encoding spastin, a putative nuclear AAA protein, has recently been identified. Here, sequence analysis of the 17 exons of SPG4 in 87 unrelated AD‐HSP patients has resulted in the detection of 34 novel mutations. These SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense (28%), nonsense (15%) and splice site point (26.5%) mutations as well as deletions (23%) and insertions (7.5%). The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers (14/238) and patients unaware of symptoms (45/238), and permitted the redefinition of this frequent form of AD-HSP.
Related content
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia
By Fonknechten Nùria Mavel Delphine Byrne Paula Davoine Claire-Sophie Cruaud Corinne Bönsch Dominikus Samson Delphine Coutinho Paula Hutchinson Michael McMonagle Paul Burgunder Jean-Marc Tartaglione Antonio Heinzlef Olivier Feki Imed Deufel Thomas Parfrey Nollaig Brice Alexis Fontaine Bertrand Prud'homme Jean-François Weissenbach Jean Dürr Alexandra Hazan Jamilé
Human Molecular Genetics, Vol. 14, Iss. 3, 2005-02 ,pp. :
Access to resources
Recommend
By Du Fang Ozdowski Emily F. Kotowski Ingrid K. Marchuk Douglas A. Sherwood Nina Tang
Human Molecular Genetics, Vol. 19, Iss. 10, 2010-05 ,pp. :